BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 17668088)

  • 1. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems.
    Trewyn BG; Giri S; Slowing II; Lin VS
    Chem Commun (Camb); 2007 Aug; (31):3236-45. PubMed ID: 17668088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.
    Lai CY; Trewyn BG; Jeftinija DM; Jeftinija K; Xu S; Jeftinija S; Lin VS
    J Am Chem Soc; 2003 Apr; 125(15):4451-9. PubMed ID: 12683815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous materials for drug delivery.
    Vallet-Regí M; Balas F; Arcos D
    Angew Chem Int Ed Engl; 2007; 46(40):7548-58. PubMed ID: 17854012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
    Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa.
    Vivero-Escoto JL; Slowing II; Lin VS
    Biomaterials; 2010 Feb; 31(6):1325-33. PubMed ID: 19932923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Textural manipulation of mesoporous materials for hosting of metallic nanocatalysts.
    Sun J; Bao X
    Chemistry; 2008; 14(25):7478-88. PubMed ID: 18668502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP.
    Zhao Y; Trewyn BG; Slowing II; Lin VS
    J Am Chem Soc; 2009 Jun; 131(24):8398-400. PubMed ID: 19476380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monodispersed mesoporous silica nanoparticles with very large pores for enhanced adsorption and release of DNA.
    Gao F; Botella P; Corma A; Blesa J; Dong L
    J Phys Chem B; 2009 Feb; 113(6):1796-804. PubMed ID: 19152258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.
    Giri S; Trewyn BG; Lin VS
    Nanomedicine (Lond); 2007 Feb; 2(1):99-111. PubMed ID: 17716196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity.
    Lin YS; Haynes CL
    J Am Chem Soc; 2010 Apr; 132(13):4834-42. PubMed ID: 20230032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuning stability of mesoporous silica films under biologically relevant conditions through processing with supercritical CO2.
    Li X; Barua S; Rege K; Vogt BD
    Langmuir; 2008 Oct; 24(20):11935-41. PubMed ID: 18795807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionalized mesoporous silica materials for controlled drug delivery.
    Yang P; Gai S; Lin J
    Chem Soc Rev; 2012 May; 41(9):3679-98. PubMed ID: 22441299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adsorption and release of biocides with mesoporous silica nanoparticles.
    Popat A; Liu J; Hu Q; Kennedy M; Peters B; Lu GQ; Qiao SZ
    Nanoscale; 2012 Feb; 4(3):970-5. PubMed ID: 22200056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release.
    Trewyn BG; Slowing II; Giri S; Chen HT; Lin VS
    Acc Chem Res; 2007 Sep; 40(9):846-53. PubMed ID: 17645305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
    Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
    Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles.
    Zhang J; Li X; Rosenholm JM; Gu HC
    J Colloid Interface Sci; 2011 Sep; 361(1):16-24. PubMed ID: 21689824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silicon-polymer hybrid materials for drug delivery.
    McInnes SJ; Voelcker NH
    Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
    Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
    Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoporous calcium silicate for controlled release of bovine serum albumin protein.
    Xue W; Bandyopadhyay A; Bose S
    Acta Biomater; 2009 Jun; 5(5):1686-96. PubMed ID: 19249262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.